2002
DOI: 10.1093/embo-reports/kvf124
|View full text |Cite
|
Sign up to set email alerts
|

A γ‐secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish

Abstract: Inhibition of amyloid β-peptide (Aβ) production by blocking γ-secretase activity is at present one of the most promising therapeutic strategies to slow progression of Alzheimer's disease pathology. γ-secretase inhibitors apparently block Aβ generation via interference with presenilin (PS) function. Besides being an essential component of the γ-secretase complex, PS itself may be an aspartyl protease with γ-secretase activity, which is not only required for Aβ production but also for a similar proteolytic proce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
405
0
3

Year Published

2003
2003
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 466 publications
(421 citation statements)
references
References 58 publications
11
405
0
3
Order By: Relevance
“…20,21 To determine whether inactivation of Notch signaling by GSI affects the expression level of Dll1, we investigated the effects of DAPT on Dll1 mRNA expression in Het-1A, CP-A, and BAR-T cells and found that it increased endogenous Dll1 mRNA expression in a concentration-and time-dependent manner, peaking at 24 h (Figures 3a and b). Effective inhibition of Notch signaling was confirmed by expression of the intracellular-gamma-secretase cleaved Notch1 fragment using a specific antibody, as well as Hes1 and ATOH1 expression levels (Figures 3c and d).…”
Section: Gsi Enhances Dll1 Expression In Human Esophageal Cellsmentioning
confidence: 99%
“…20,21 To determine whether inactivation of Notch signaling by GSI affects the expression level of Dll1, we investigated the effects of DAPT on Dll1 mRNA expression in Het-1A, CP-A, and BAR-T cells and found that it increased endogenous Dll1 mRNA expression in a concentration-and time-dependent manner, peaking at 24 h (Figures 3a and b). Effective inhibition of Notch signaling was confirmed by expression of the intracellular-gamma-secretase cleaved Notch1 fragment using a specific antibody, as well as Hes1 and ATOH1 expression levels (Figures 3c and d).…”
Section: Gsi Enhances Dll1 Expression In Human Esophageal Cellsmentioning
confidence: 99%
“…The absolute cell numbers with control Fc are ϳ5-fold higher than that with Delta4-Fc, and the fold increases in the cell number after the 3-wk culture were 45.7 Ϯ 31.6-fold (n ϭ 11). To confirm that the NK cell differentiation was Notch dependent, we added a ␥-secretase inhibitor, DAPT, which strongly inhibits ligand-dependent Notch activation (24,25). The cells cultured on Delta4-Fc-coated plates in the presence of DAPT had the same immunophenotype as those cultured on the control Fc-coated plates and did not give rise to NK cells (Fig.…”
Section: Human Cb Cd34 ϩ and Cd133 ϩ Cells Gave Rise To Functional Nkmentioning
confidence: 99%
“…To test if this is a plausible mechanism for p53 induction in activated T cells, we first modulated cMyc expression through the indirect inhibition of Notch by DAPT, a g-secretase inhibitor. 37,24 Treatment with DAPT lowered cMyc levels and proliferation of activated T cells. 23 The cMyc target p14ARF was also downregulated in these cells.…”
Section: Discussionmentioning
confidence: 99%
“…23 In order to further study the regulatory interplay between cMyc and p53, we tested the effect of Notch inhibition by DAPT 24 (g secretase inhibitor) in activated T cells. This treatment lead to decreased T cell proliferation in a dose-dependent manner (Fig.…”
Section: High P53 Levels Downregulate Cmyc Expression In Activated T mentioning
confidence: 99%